vs
Side-by-side financial comparison of GLOBAL INDUSTRIAL Co (GIC) and Bio-Techne (TECH). Click either name above to swap in a different company.
GLOBAL INDUSTRIAL Co is the larger business by last-quarter revenue ($345.6M vs $295.9M, roughly 1.2× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 4.2%, a 8.6% gap on every dollar of revenue. On growth, GLOBAL INDUSTRIAL Co posted the faster year-over-year revenue change (14.3% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 3.4%).
Global Industrial Company is a Port Washington, New York–based company providing industrial and MRO products through a system of branded e-Commerce websites and relationship marketers in North America. The primary brand is Global Industrial.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
GIC vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $345.6M | $295.9M |
| Net Profit | $14.6M | $38.0M |
| Gross Margin | 34.5% | 64.6% |
| Operating Margin | 5.7% | 18.4% |
| Net Margin | 4.2% | 12.8% |
| Revenue YoY | 14.3% | -6.4% |
| Net Profit YoY | 36.4% | 68.3% |
| EPS (diluted) | $0.37 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $345.6M | $295.9M | ||
| Q3 25 | $353.6M | — | ||
| Q2 25 | $358.9M | $317.0M | ||
| Q1 25 | $321.0M | $316.2M | ||
| Q4 24 | $302.3M | $297.0M | ||
| Q3 24 | $342.4M | $289.5M | ||
| Q2 24 | $347.8M | $306.1M | ||
| Q1 24 | $323.4M | $303.4M |
| Q4 25 | $14.6M | $38.0M | ||
| Q3 25 | $18.8M | — | ||
| Q2 25 | $25.1M | $-17.7M | ||
| Q1 25 | $13.6M | $22.6M | ||
| Q4 24 | $10.7M | $34.9M | ||
| Q3 24 | $16.8M | $33.6M | ||
| Q2 24 | $20.3M | $40.6M | ||
| Q1 24 | $13.2M | $49.1M |
| Q4 25 | 34.5% | 64.6% | ||
| Q3 25 | 35.6% | — | ||
| Q2 25 | 37.1% | 62.7% | ||
| Q1 25 | 34.9% | 67.9% | ||
| Q4 24 | 33.8% | 65.3% | ||
| Q3 24 | 34.0% | 63.2% | ||
| Q2 24 | 35.2% | 66.4% | ||
| Q1 24 | 34.3% | 67.4% |
| Q4 25 | 5.7% | 18.4% | ||
| Q3 25 | 7.4% | — | ||
| Q2 25 | 9.3% | -7.5% | ||
| Q1 25 | 5.7% | 12.2% | ||
| Q4 24 | 4.8% | 16.0% | ||
| Q3 24 | 6.5% | 13.8% | ||
| Q2 24 | 7.6% | 15.0% | ||
| Q1 24 | 5.4% | 22.1% |
| Q4 25 | 4.2% | 12.8% | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 7.0% | -5.6% | ||
| Q1 25 | 4.2% | 7.1% | ||
| Q4 24 | 3.5% | 11.7% | ||
| Q3 24 | 4.9% | 11.6% | ||
| Q2 24 | 5.8% | 13.3% | ||
| Q1 24 | 4.1% | 16.2% |
| Q4 25 | $0.37 | $0.24 | ||
| Q3 25 | $0.48 | — | ||
| Q2 25 | $0.65 | $-0.11 | ||
| Q1 25 | $0.35 | $0.14 | ||
| Q4 24 | $0.28 | $0.22 | ||
| Q3 24 | $0.44 | $0.21 | ||
| Q2 24 | $0.52 | $0.26 | ||
| Q1 24 | $0.34 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $67.5M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $313.2M | $2.0B |
| Total Assets | $580.8M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.5M | $172.9M | ||
| Q3 25 | $67.2M | — | ||
| Q2 25 | $55.1M | $162.2M | ||
| Q1 25 | $39.0M | $140.7M | ||
| Q4 24 | $44.6M | $177.5M | ||
| Q3 24 | $38.9M | $187.5M | ||
| Q2 24 | $38.8M | $152.9M | ||
| Q1 24 | $29.9M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $313.2M | $2.0B | ||
| Q3 25 | $316.0M | — | ||
| Q2 25 | $305.2M | $1.9B | ||
| Q1 25 | $287.9M | $2.0B | ||
| Q4 24 | $281.1M | $2.1B | ||
| Q3 24 | $279.2M | $2.1B | ||
| Q2 24 | $270.4M | $2.1B | ||
| Q1 24 | $260.2M | $2.0B |
| Q4 25 | $580.8M | $2.5B | ||
| Q3 25 | $602.5M | — | ||
| Q2 25 | $586.5M | $2.6B | ||
| Q1 25 | $536.7M | $2.6B | ||
| Q4 24 | $520.7M | $2.7B | ||
| Q3 24 | $531.6M | $2.7B | ||
| Q2 24 | $542.5M | $2.7B | ||
| Q1 24 | $517.4M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | — |
| Free Cash FlowOCF − Capex | $19.2M | — |
| FCF MarginFCF / Revenue | 5.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 1.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | $74.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.0M | — | ||
| Q3 25 | $22.7M | — | ||
| Q2 25 | $31.7M | $98.2M | ||
| Q1 25 | $3.4M | $41.1M | ||
| Q4 24 | $15.9M | $84.3M | ||
| Q3 24 | $9.6M | $63.9M | ||
| Q2 24 | $18.8M | $75.5M | ||
| Q1 24 | $6.4M | $81.0M |
| Q4 25 | $19.2M | — | ||
| Q3 25 | $22.0M | — | ||
| Q2 25 | $30.3M | $93.3M | ||
| Q1 25 | $3.2M | $31.0M | ||
| Q4 24 | $15.2M | $77.5M | ||
| Q3 24 | $8.7M | $54.7M | ||
| Q2 24 | $17.9M | $57.5M | ||
| Q1 24 | $5.1M | $64.5M |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 8.4% | 29.4% | ||
| Q1 25 | 1.0% | 9.8% | ||
| Q4 24 | 5.0% | 26.1% | ||
| Q3 24 | 2.5% | 18.9% | ||
| Q2 24 | 5.1% | 18.8% | ||
| Q1 24 | 1.6% | 21.3% |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.4% | 1.5% | ||
| Q1 25 | 0.1% | 3.2% | ||
| Q4 24 | 0.2% | 2.3% | ||
| Q3 24 | 0.3% | 3.2% | ||
| Q2 24 | 0.3% | 5.9% | ||
| Q1 24 | 0.4% | 5.4% |
| Q4 25 | 1.37× | — | ||
| Q3 25 | 1.21× | — | ||
| Q2 25 | 1.26× | — | ||
| Q1 25 | 0.25× | 1.82× | ||
| Q4 24 | 1.49× | 2.42× | ||
| Q3 24 | 0.57× | 1.90× | ||
| Q2 24 | 0.93× | 1.86× | ||
| Q1 24 | 0.48× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GIC
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
